Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions

Revised
ISBN: 978-0-444-53717-1
Verlag: PAPERBACKSHOP UK IMPORT

Buch, Englisch, 7674 Seiten, Format (B × H): 220 mm x 282 mm, Gewicht: 23350 g

Reihe: Meyler's Side Effects of Drugs

Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, Sixteenth Edition, Seven Volume Set builds on the success of the 15 previous editions, providing an extensively reorganized and expanded resource that now comprises more than 1,500 individual drug articles with the most complete coverage of adverse reactions and interactions found anywhere.

Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature, making this a must-have reference work for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary, or pharmaceutical company.

The online version of the book provides an unparalleled depth of coverage and functionality by offering convenient desktop access and enhanced features such as increased searchability, extensive internal cross-linking, and fully downloadable and printable full-text, HTML or PDF articles.

Zielgruppe

Academic and medical libraries, clinical pharmacologists, pharmacists in the pharmaceutical industry, regulatory organizations, and hospital dispensaries

Autoren/Hrsg.

Aronson, Jeffrey K.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

Contributors
Foreword
Contents
How to use this book
Overview of Drug Monographs
Preface
Drug Monographs
Index of Drug Names
Index of Adverse Reactions

Über Autor(innen)

Aronson, Jeffrey K.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.